FDA Urges Pharma to Publish Trial Data, Warns of 'Distorted' Evidence Base

(MedPage Today) -- The FDA said it reminded more than 2,000 pharmaceutical companies and researchers about legal requirements to publish clinical trial data, warning that a publication preference for positive trials could be skewing the available...
Source
MedPage Today
Opens original article in a new tab



